New treatments for Alport Syndrome
Innovative Approaches to Treating Alport Syndrome
This study is looking into what causes Alport Syndrome, a kidney disease, by examining how certain genetic changes affect the kidney's structure, and it hopes to find new treatments that can help keep your kidneys healthy and slow down the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10873319 on NIH RePORTER |
What this research studies
This research investigates the underlying causes of Alport Syndrome, a genetic kidney disease that can lead to kidney failure and other complications. The team focuses on the glomerular basement membrane, which is crucial for kidney function, and how mutations in collagen IV affect its structure and function. By understanding these mechanisms, the researchers aim to develop innovative treatment approaches that could improve kidney health and prevent disease progression. Patients may be involved in trials that test new therapies targeting these specific genetic defects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alport Syndrome or related hereditary nephritis conditions.
Not a fit: Patients with kidney diseases unrelated to Alport Syndrome or those without genetic predispositions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve kidney function and quality of life for patients with Alport Syndrome.
How similar studies have performed: Previous research has shown promise in understanding genetic kidney diseases, but this specific approach to Alport Syndrome is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Miner, Jeffrey H — Washington University
- Study coordinator: Miner, Jeffrey H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.